Global Lipidomics Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Lipidomics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Blood Sample
  • 1.2.3 Tissue Sample
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Lipidomics Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Drug Discovery
  • 1.3.3 Biomarker Discovery
  • 1.3.4 Personalized Medicine
  • 1.3.5 Diagnosis and Treatment
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Lipidomics Market Perspective (2016-2027)
• 2.2 Lipidomics Growth Trends by Regions
  • 2.2.1 Lipidomics Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Lipidomics Historic Market Share by Regions (2016-2021)
  • 2.2.3 Lipidomics Forecasted Market Size by Regions (2022-2027)
• 2.3 Lipidomics Industry Dynamic
  • 2.3.1 Lipidomics Market Trends
  • 2.3.2 Lipidomics Market Drivers
  • 2.3.3 Lipidomics Market Challenges
  • 2.3.4 Lipidomics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Lipidomics Players by Revenue
  • 3.1.1 Global Top Lipidomics Players by Revenue (2016-2021)
  • 3.1.2 Global Lipidomics Revenue Market Share by Players (2016-2021)
• 3.2 Global Lipidomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Lipidomics Revenue
• 3.4 Global Lipidomics Market Concentration Ratio
  • 3.4.1 Global Lipidomics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lipidomics Revenue in 2020
• 3.5 Lipidomics Key Players Head office and Area Served
• 3.6 Key Players Lipidomics Product Solution and Service
• 3.7 Date of Enter into Lipidomics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Lipidomics Breakdown Data by Type

• 4.1 Global Lipidomics Historic Market Size by Type (2016-2021)
• 4.2 Global Lipidomics Forecasted Market Size by Type (2022-2027)

5 Lipidomics Breakdown Data by Application

• 5.1 Global Lipidomics Historic Market Size by Application (2016-2021)
• 5.2 Global Lipidomics Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Lipidomics Market Size (2016-2027)
• 6.2 North America Lipidomics Market Size by Type
  • 6.2.1 North America Lipidomics Market Size by Type (2016-2021)
  • 6.2.2 North America Lipidomics Market Size by Type (2022-2027)
  • 6.2.3 North America Lipidomics Market Size by Type (2016-2027)
• 6.3 North America Lipidomics Market Size by Application
  • 6.3.1 North America Lipidomics Market Size by Application (2016-2021)
  • 6.3.2 North America Lipidomics Market Size by Application (2022-2027)
  • 6.3.3 North America Lipidomics Market Size by Application (2016-2027)
• 6.4 North America Lipidomics Market Size by Country
  • 6.4.1 North America Lipidomics Market Size by Country (2016-2021)
  • 6.4.2 North America Lipidomics Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Lipidomics Market Size (2016-2027)
• 7.2 Europe Lipidomics Market Size by Type
  • 7.2.1 Europe Lipidomics Market Size by Type (2016-2021)
  • 7.2.2 Europe Lipidomics Market Size by Type (2022-2027)
  • 7.2.3 Europe Lipidomics Market Size by Type (2016-2027)
• 7.3 Europe Lipidomics Market Size by Application
  • 7.3.1 Europe Lipidomics Market Size by Application (2016-2021)
  • 7.3.2 Europe Lipidomics Market Size by Application (2022-2027)
  • 7.3.3 Europe Lipidomics Market Size by Application (2016-2027)
• 7.4 Europe Lipidomics Market Size by Country
  • 7.4.1 Europe Lipidomics Market Size by Country (2016-2021)
  • 7.4.2 Europe Lipidomics Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Lipidomics Market Size (2016-2027)
• 8.2 Asia-Pacific Lipidomics Market Size by Type
  • 8.2.1 Asia-Pacific Lipidomics Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Lipidomics Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Lipidomics Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Lipidomics Market Size by Application
  • 8.3.1 Asia-Pacific Lipidomics Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Lipidomics Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Lipidomics Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Lipidomics Market Size by Region
  • 8.4.1 Asia-Pacific Lipidomics Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Lipidomics Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Lipidomics Market Size (2016-2027)
• 9.2 Latin America Lipidomics Market Size by Type
  • 9.2.1 Latin America Lipidomics Market Size by Type (2016-2021)
  • 9.2.2 Latin America Lipidomics Market Size by Type (2022-2027)
  • 9.2.3 Latin America Lipidomics Market Size by Type (2016-2027)
• 9.3 Latin America Lipidomics Market Size by Application
  • 9.3.1 Latin America Lipidomics Market Size by Application (2016-2021)
  • 9.3.2 Latin America Lipidomics Market Size by Application (2022-2027)
  • 9.3.3 Latin America Lipidomics Market Size by Application (2016-2027)
• 9.4 Latin America Lipidomics Market Size by Country
  • 9.4.1 Latin America Lipidomics Market Size by Country (2016-2021)
  • 9.4.2 Latin America Lipidomics Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Lipidomics Market Size (2016-2027)
• 10.2 Middle East & Africa Lipidomics Market Size by Type
  • 10.2.1 Middle East & Africa Lipidomics Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Lipidomics Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Lipidomics Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Lipidomics Market Size by Application
  • 10.3.1 Middle East & Africa Lipidomics Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Lipidomics Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Lipidomics Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Lipidomics Market Size by Country
  • 10.4.1 Middle East & Africa Lipidomics Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Lipidomics Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Zora Biosciences OY
  • 11.1.1 Zora Biosciences OY Company Details
  • 11.1.2 Zora Biosciences OY Business Overview
  • 11.1.3 Zora Biosciences OY Lipidomics Introduction
  • 11.1.4 Zora Biosciences OY Revenue in Lipidomics Business (2016-2021)
  • 11.1.5 Zora Biosciences OY Recent Development
• 11.2 Owl Metabolomics
  • 11.2.1 Owl Metabolomics Company Details
  • 11.2.2 Owl Metabolomics Business Overview
  • 11.2.3 Owl Metabolomics Lipidomics Introduction
  • 11.2.4 Owl Metabolomics Revenue in Lipidomics Business (2016-2021)
  • 11.2.5 Owl Metabolomics Recent Development
• 11.3 Avanti Lipids Polar, Inc.
  • 11.3.1 Avanti Lipids Polar, Inc. Company Details
  • 11.3.2 Avanti Lipids Polar, Inc. Business Overview
  • 11.3.3 Avanti Lipids Polar, Inc. Lipidomics Introduction
  • 11.3.4 Avanti Lipids Polar, Inc. Revenue in Lipidomics Business (2016-2021)
  • 11.3.5 Avanti Lipids Polar, Inc. Recent Development
• 11.4 The Metabolomics Innovation Centre
  • 11.4.1 The Metabolomics Innovation Centre Company Details
  • 11.4.2 The Metabolomics Innovation Centre Business Overview
  • 11.4.3 The Metabolomics Innovation Centre Lipidomics Introduction
  • 11.4.4 The Metabolomics Innovation Centre Revenue in Lipidomics Business (2016-2021)
  • 11.4.5 The Metabolomics Innovation Centre Recent Development
• 11.5 Lipotype GmbH
  • 11.5.1 Lipotype GmbH Company Details
  • 11.5.2 Lipotype GmbH Business Overview
  • 11.5.3 Lipotype GmbH Lipidomics Introduction
  • 11.5.4 Lipotype GmbH Revenue in Lipidomics Business (2016-2021)
  • 11.5.5 Lipotype GmbH Recent Development
• 11.6 Metabolon, Inc.
  • 11.6.1 Metabolon, Inc. Company Details
  • 11.6.2 Metabolon, Inc. Business Overview
  • 11.6.3 Metabolon, Inc. Lipidomics Introduction
  • 11.6.4 Metabolon, Inc. Revenue in Lipidomics Business (2016-2021)
  • 11.6.5 Metabolon, Inc. Recent Development
• 11.7 Waters Corporation
  • 11.7.1 Waters Corporation Company Details
  • 11.7.2 Waters Corporation Business Overview
  • 11.7.3 Waters Corporation Lipidomics Introduction
  • 11.7.4 Waters Corporation Revenue in Lipidomics Business (2016-2021)
  • 11.7.5 Waters Corporation Recent Development
• 11.8 Creative Proteomics
  • 11.8.1 Creative Proteomics Company Details
  • 11.8.2 Creative Proteomics Business Overview
  • 11.8.3 Creative Proteomics Lipidomics Introduction
  • 11.8.4 Creative Proteomics Revenue in Lipidomics Business (2016-2021)
  • 11.8.5 Creative Proteomics Recent Development
• 11.9 Thermo Fisher Scientific
  • 11.9.1 Thermo Fisher Scientific Company Details
  • 11.9.2 Thermo Fisher Scientific Business Overview
  • 11.9.3 Thermo Fisher Scientific Lipidomics Introduction
  • 11.9.4 Thermo Fisher Scientific Revenue in Lipidomics Business (2016-2021)
  • 11.9.5 Thermo Fisher Scientific Recent Development
• 11.10 MetaSysX
  • 11.10.1 MetaSysX Company Details
  • 11.10.2 MetaSysX Business Overview
  • 11.10.3 MetaSysX Lipidomics Introduction
  • 11.10.4 MetaSysX Revenue in Lipidomics Business (2016-2021)
  • 11.10.5 MetaSysX Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer